Skip to content

Iron Deficiency Anemia in Childern With Liver Cirrhosis

Prevelance of Iron Deficiency Anemia in Liver Cirrhosis in Childern

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03482076
Acronym
IDA
Enrollment
50
Registered
2018-03-29
Start date
2019-03-01
Completion date
2020-06-01
Last updated
2018-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency, Anaemia in Children, Liver Cirrhosis

Brief summary

Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients

Detailed description

Patients with cirrhosis are at risk of developing both IDA and anemia of chronic disease concomitantly, and there adverse effects can deteriorate general condition and affect of quality of life in these patients .Also because it is easier to correct IDA than anemia of chronic disease, so this study of the prevalence of IDA helping us in the diagnosis and treatment of IDA and can reduce the need for other diagnostic tests and improve the quality of life in patients with cirrhosis .

Interventions

DIAGNOSTIC_TESTtransferrin receptor concentration

Sandwich radio-imunoassay

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* all childern with liver cirrhosis in GIT and hepatology unit

Exclusion criteria

* Neonates less than one month * childern with other liver diseases

Design outcomes

Primary

MeasureTime frameDescription
Prevelance of IDA in liver cirrhosistwo yearsTo evaluate results

Contacts

Primary ContactBahaa Khaled Mohamed
drbahaakhaled@gmail.com+201002755105
Backup ContactNagla Hassan Ibrahim

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026